fluoxetine has been researched along with nadp in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albert, RH; Jin, Y; Lewis, M; Palackal, NT; Penning, TM; Stayrook, SE | 1 |
Murray, K; Murray, M | 1 |
Crespi, CL; Dandeneau, AA; Dehal, SS; Ho, T; Mason, AK; Morgan, L; Perloff, ES; Stresser, DM | 1 |
Filipović, D; Todorović, N | 1 |
Asuquo, EB; Dalmizrak, O; Ogus, IH; Ozer, N; Teralı, K | 1 |
5 other study(ies) available for fluoxetine and nadp
Article | Year |
---|---|
Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate.
Topics: Allosteric Regulation; Allosteric Site; Amino Acid Sequence; Binding Sites; Cloning, Molecular; Computer Simulation; Crystallography, X-Ray; Escherichia coli; Fluoxetine; Humans; Hydroxysteroid Dehydrogenases; Models, Molecular; Molecular Conformation; Molecular Sequence Data; NADP; Protein Binding; Protein Structure, Secondary; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Ursodeoxycholic Acid | 2001 |
Mechanism-based inhibition of CYP activities in rat liver by fluoxetine and structurally similar alkylamines.
Topics: Adrenergic Uptake Inhibitors; Amines; Animals; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cytochrome P450 Family 2; Desipramine; Diffusion; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Heme; Hydroxylation; Inhibitory Concentration 50; Kinetics; Liver; Male; Microsomes, Liver; Models, Chemical; NADP; Nortriptyline; Oxygen; Protein Binding; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Steroid 16-alpha-Hydroxylase; Steroids; Time Factors | 2003 |
Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine.
Topics: Aryl Hydrocarbon Hydroxylases; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Fluoxetine; Humans; Microsomes, Liver; NADP; Selective Serotonin Reuptake Inhibitors; Stereoisomerism; Tandem Mass Spectrometry | 2009 |
Prefrontal cortical glutathione-dependent defense and proinflammatory mediators in chronically isolated rats: Modulation by fluoxetine or clozapine.
Topics: Animals; Antidepressive Agents; Clozapine; Cytokines; Defense Mechanisms; Disease Models, Animal; Fluoxetine; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Male; Mood Disorders; NADP; NF-kappa B; Nitric Oxide Synthase Type II; Prefrontal Cortex; Rats; Rats, Wistar; Social Isolation | 2017 |
The Relevance of Glutathione Reductase Inhibition by Fluoxetine to Human Health and Disease: Insights Derived from a Combined Kinetic and Docking Study.
Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6 Inhibitors; Enzyme Inhibitors; Fluoxetine; Glutathione Reductase; Humans; Kinetics; Molecular Docking Simulation; NADP; Selective Serotonin Reuptake Inhibitors | 2019 |